Merni Stringfellow
Family · Welaka, FLNPI 1083777031
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 42 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $887 and has fallen 65.9% since, to $303 in 2025.
Across 42 payments — averaging $83.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$406
- Boston Scientific$398
- Genentech USA, Inc.$229
- Sanofi$165
- Novo Nordisk$162
- Medtronic$160
- plus $2K from 20 others
What the payments were for
- Food & beverage$3,494100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 4 | $406 |
| Boston Scientific | 4 | $398 |
| Genentech USA, Inc. | 2 | $229 |
| Sanofi | 2 | $165 |
| Novo Nordisk | 3 | $162 |
| Medtronic | 3 | $160 |
| Dexcom, Inc. | 1 | $142 |
| Pharming Healthcare, Inc. | 1 | $130 |
| Neurocrine Biosciences, Inc. | 1 | $129 |
| AbbVie | 2 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| BD | 1 | $124 |
| Johnson & Johnson | 2 | $116 |
| ZOLL Respicardia, Inc. | 1 | $115 |
| Relievant Medsystems, Inc. | 1 | $115 |
| Pulmonx Corporation | 1 | $110 |
| Janssen Scientific Affairs, LLC | 1 | $106 |
| Lilly USA, LLC | 1 | $96 |
| Hill-rom Company, Inc | 1 | $95 |
| Medline Industries LP | 1 | $88 |
| AstraZeneca | 1 | $83 |
| Amgen | 1 | $77 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $76 |
| Coloplast | 1 | $63 |
| Pfizer | 2 | $32 |
| GSK | 2 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$327
- Intracept$229
- WATCHMAN Access System$222
- DEXCOM G7 GSS (161)$142
- Xofluza$136
- RUCONEST$130
- INGREZZA$129
- REXULTI$125
- remede System$115
- WATCHMAN FLX$112
- CHARTIS CATHETER$110
- ZEPHYR DELIVERY CATHETER$110
- ZEPHYR ENDOBRONCHIAL VALVE$110
- PULMONX CHARTIS TABLET CONSOLE$110
- UBRELVY$108
- Tremfya$106
How this compares
$3,494 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.
Other family in Welaka
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.